0 items USD 0.00Search
Your search for "ctDNA" gave back 92 results.
Global Liquid Biopsy Products market will register a 27.8% CAGR in terms of revenue, reach US$ 2710 million by 2023, from US$ 620 million in 2017. (...
颁补迟补濒辞驳:听
MRRPB2
January 2023
Price: USD 4,960.00
The global market for Cell-free Tumor DNA Detection was valued at US$ 6051 million in the year 2024 and is projected to reach a revised size of US$...
颁补迟补濒辞驳:听
MRRPB5
March 2025
Price: USD 2,900.00
The global market for Liquid Biopsy Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by...
颁补迟补濒辞驳:听
MRRPB5
February 2025
Price: USD 2,900.00
The global Hemato Oncology Testing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a...
颁补迟补濒辞驳:听
GIR
January 2025
Price: USD 3,480.00
The global Liquid Biopsy Products market size was valued at US$ 2252 million in 2024 and is forecast to a readjusted size of USD 10510 million by...
颁补迟补濒辞驳:听
GIR
January 2025
Price: USD 3,480.00
The global Cell-Free DNA (cfDNA) Testing market size was valued at US$ million in 2023. With growing demand in downstream market, the Cell-Free DNA (...
颁补迟补濒辞驳:听
LPI
November 2024
Price: USD 3,660.00
Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called "liquid biopsy". ctDNA refers to the DNA released by tumor cells...
颁补迟补濒辞驳:听
MRRPB5
June 2024
Price: USD 2,900.00
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring...
颁补迟补濒辞驳:听
MRRPB5
June 2024
Price: USD 5,900.00
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 5,900.00
Liquid biopsy technology is a non-invasive diagnostic approach that involves the analysis of biomarkers and genetic material (such as circulating...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 2,900.00
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring...
颁补迟补濒辞驳:听
GIR
August 2024
Price: USD 3,480.00
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as...
颁补迟补濒辞驳:听
GIR
September 2024
Price: USD 3,480.00
The global Liquid Biopsy Technology market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a...
颁补迟补濒辞驳:听
GIR
April 2025
Price: USD 3,480.00
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as...
颁补迟补濒辞驳:听
MRRPB5
July 2024
Price: USD 4,900.00
Liquid biopsy technology is a non-invasive diagnostic approach that involves the analysis of biomarkers and genetic material (such as circulating...
颁补迟补濒辞驳:听
MRRPB5
November 2024
Price: USD 4,900.00
听
